ResMed Sleep And Breathing Health — Selling, general, and administrative increased by 1.2% to $149.51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.0%, from $121.56M to $149.51M. Over 2 years (FY 2023 to FY 2025), Sleep And Breathing Health — Selling, general, and administrative shows an upward trend with a 5.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising costs may indicate aggressive market expansion, while declining costs relative to revenue suggest improved operating leverage.
Captures the indirect operating expenses required to support the Sleep and Breathing Health segment, including sales for...
Commonly reported as SG&A expense in segment reporting for diversified healthcare companies.
rmd_segment_sleep_and_breathing_health_selling_general_and_administrative| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $110.87M | $110.87M | $110.87M | $110.87M | $112.83M | $112.83M | $112.83M | $112.83M | $109.41M | $118.83M | $121.56M | $141.78M | $134.73M | $147.74M | $149.51M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +1.8% | +0.0% | +0.0% | +0.0% | -3.0% | +8.6% | +2.3% | +16.6% | -5.0% | +9.7% | +1.2% |
| YoY Change | — | — | — | — | +1.8% | +1.8% | +1.8% | +1.8% | -3.0% | +5.3% | +7.7% | +25.7% | +23.1% | +24.3% | +23.0% |